Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Clinical trial NCT04490564 · COMPLETED
Trial details
- NCT number
- NCT04490564
- Sponsor
- Pharmassist Ltd
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-06-25
- Primary completion
- 2022-09-07
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.